USPTO serial 97933294
REALM
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- KERTGATE, AMY L
- Law office
- TMO LAW OFFICE 113 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with REALM?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Aliso Viejo, CA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Carrie L. Kiedrowski
CARRIE L. KIEDROWSKI JONES DAY250 VESEY STREETNEW YORK, NY 10281-1047UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Research and development in the fields of personalized medicine and diagnostics; data mining of healthcare and genetic information in the field of precision medicine and personalized medicine; scientific study and research in the fields of biochemistry, disease, personalized medicine, personalized therapeutics, and/or pharmaceuticals; clinical and medical laboratory testing services in the fields of disease diagnostics and personalized medicine; pharmaceutical drug research and development; custom assay development; pharmaceutical drug discovery and development services; providing laboratory research services in the field of medical diagnostics and personalized medicine; medical research services; biotechnology research; providing medical and scientific research information in the field of clinical trials; research and development of vaccines and therapeutics; data collection services for scientific research purposes in the fields of genomics, healthcare and precision medicine; pharmaceutical research in connection with human genetics and programmable biology; pharmaceutical research in the fields of angiology, cardiology, endocrinology, gastroenterology, geriatrics, hematology, hepatology, nephrology, neurology, oncology, pulmonology, pneumology, respirology, rheumatology, anesthesiology, urology, dermatology, gynecology, ophthalmology, infectiology, and psychiatry; pharmaceutical research in the fields of pediatric, geriatric, emergency, family, and preventative medicine; pharmaceutical research in the field of treatment of infectious, deficiency, hereditary, and physiological diseases; medical research in connection with various diseases and disorders, including eosinophilic diseases, asthma, CRS, and allergic rhinitis, autoimmune diseases, including psoriasis, vitiligo, and lichen planus, ocular diseases, including intraocular pressure and glaucoma, and atopic dermatitis; scientific, technological, research services for collecting, analyzing, monitoring, reporting or tracking data and information in the fields of physiology, biology, genetics, genomics, metagenomics, microbiome, metabolomics, proteomics, glycomics or biochemistry; scientific, technological, research services for collecting, analyzing, monitoring, reporting or tracking data and information in relation to probiotics, prebiotics or nutraceutical supplements; scientific, technological, research services for collecting, analyzing, monitoring, reporting or tracking data and information in relation to health, wellness, physical well-being, mental well-being, exercise, weight planning or weight management; scientific, technological, research services for collecting, analyzing, monitoring, reporting or tracking data and information in relation to diet, food or nutrition; scientific, technological, research services for collecting, analyzing, monitoring, reporting or tracking data and information in relation to sleep, exercise or consciousness; scientific, technological, research services in the fields of physiology, biology, genetics, genomics, metagenomics, microbiome, metabolomics, proteomics, glycomics or biochemistry; scientific, technological, research services in relation to health, wellness, physical well-being, mental well-being, exercise, weight planning or weight management; scientific, technological, research services in relation to diet, food or nutrition; scientific, technological, research services in relation to sleep, exercise or consciousness | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 30, 2024 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| May 30, 2024 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Feb 14, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 14, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 14, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 7, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 13, 2023 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Jun 12, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 16, 2023 | NWAP | NEW APPLICATION ENTERED | — |